Study Stopped
Study data collection was terminated due to COVID-19 pandemic and will not resume.
Long-Term Effectiveness of Walking Training in Patients With Knee Osteoarthritis
Personalized Gait Training With Feedback to Reduce Knee Pain From Osteoarthritis
1 other identifier
interventional
68
1 country
2
Brief Summary
Nearly one out of every two Americans will develop knee osteoarthritis by age 85. Over 20 million Americans, including nearly three million Veterans, currently have painful knee arthritis that limits their daily activity or recreation. The vast majority of those individuals will be prescribed anti-inflammatory drugs that provide some pain relief but do not slow the progression of the disease. Often people with knee arthritis are told they must live with the pain until they become appropriate candidates for knee replacement surgery, but that can require tolerating the pain and limiting function for many years. Because of other health issues, some individuals are never acceptable surgery candidates. What is desperately needed are better conservative approaches for treating these patients. Two such approaches will be tested and compared in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2016
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2016
CompletedFirst Posted
Study publicly available on registry
May 10, 2016
CompletedStudy Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2020
CompletedResults Posted
Study results publicly available
April 15, 2022
CompletedApril 15, 2022
February 1, 2022
4.3 years
May 4, 2016
November 16, 2021
February 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Medial Knee Pain
Change in medial knee pain between baseline and week 52 using an 11-point Numeric Rating Scale (NRS) to assess average medial knee pain over the past 7 day period. Possible scores range from 0 (no pain) to 10 (worst pain imaginable). Change = (Week 52 score - Baseline score).
Baseline and Week 52
Change in Knee Adduction Moment
Change in magnitude of the more prominent peak in the knee adduction moment (KAM), a surrogate measure for medio-lateral load distribution in the knee, between baseline and week 52. A reduction in KAM indicates a shift in loading from the medial to the lateral compartment of the knee. Change = (Week 52 - Baseline).
Baseline and Week 52
Secondary Outcomes (4)
Change in Medial T1rho Relaxation Time
Baseline and Week 52
Change in Medial T2 Relaxation Time
Baseline and Week 52
Change in Lateral T1rho Relaxation Time
Baseline and Week 52
Change in Lateral T2 Relaxation Time
Baseline and Week 52
Study Arms (2)
Gait Training; Altered Foot Progression Angle
EXPERIMENTALParticipants will receive personalized gait training while walking on a treadmill with real-time, haptic feedback. The goal of the training is to encourage participants to adopt an altered foot progression angle in an attempt to alter the distribution of forces crossing the knee joint. Training will occur once a week for six weeks. This will be followed by a 46-week home and community-based walking program to practice and internalize the new personalized, gait pattern and to encourage daily walking. Refresher training with haptic feedback will be offered at weeks 11, 25 and 39 to enhance internalization of the new foot progression angle.
Gait Training; Consistent Foot Progression Angle
EXPERIMENTALParticipants will receive personalized gait training while walking on a treadmill with haptic feedback. The goal of the training is to encourage participants to maintain a consistent foot progression angle in an attempt to minimize the variability in the forces crossing the knee joint. Training will occur once a week, for 6 weeks. This will be followed by a 46-week home and community-based walking program to encourage daily walking. Refresher training with haptic feedback will be offered at weeks 11, 25 and 39 to maintain foot progression angle consistency.
Interventions
Participants will receive personalized gait training while walking on a treadmill with real-time, haptic feedback to encourage them to adopt a new foot progression angle. Participants will walk for an additional ten minutes per day to internalize their new foot progression angle over 52 weeks.
Participants will receive personalized gait training while walking on a treadmill with haptic feedback to encourage them to maintain a consistent foot progression angle. Participants will walk an additional ten minutes per day to internalize the consistency of their foot progression angle over 52 weeks.
Eligibility Criteria
You may qualify if:
- Diagnosed with isolated, medial compartment knee OA of at least six months duration
- Kellgren-Lawrence grade of I, II, or III
- Age greater than 18 years at the time of enrollment
- Ability to give informed consent
- Knee pain more than three days per week on average
- Average knee pain in medial compartment between 3 and 9 on an 11-point Numerical Rating Scale, and greater than pain in other compartments
- Ambulatory without aids
- Able to walk for at least 25 consecutive minutes
- Able to walk on treadmill safely at 0.7 m/s or faster
- Able to reduce the prominent peak of the knee adduction moment by changing foot progression angle
You may not qualify if:
- Body mass index equal to or greater than 35
- Pregnancy
- Plans for knee replacement within the next 12 months
- Contraindications to MRI
- Nerve or muscle disease associated with walking difficulty
- Narcotic pain medication usage
- History of rheumatoid arthritis or autoimmune disease
- An episode of gout or pseudogout in the knee in the past year
- History of neuropathic arthropathy, infectious disease, or other major systemic diseases
- Current or recent past use (within two months) of oral corticosteroids
- Cognitive impairments that would limit a subject's understanding
- Expecting a significant change in activity level or weight within the next 12 months
- Regularly participates in high impact activities such as running, soccer, basketball, etc.
- Unable to perform the 3rd stage of the 4-stage balance test, which involves holding a tandem stance for 10 seconds
- The following criteria apply only to the affected osteoarthritic limb:
- +11 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, 94304-1290, United States
Stanford University, Depts: Bioengineering; Orthopaedics
Stanford, California, 94305, United States
Related Publications (1)
Uhlrich SD, Mazzoli V, Silder A, Finlay AK, Kogan F, Gold GE, Delp SL, Beaupre GS, Kolesar JA. Personalised gait retraining for medial compartment knee osteoarthritis: a randomised controlled trial. Lancet Rheumatol. 2025 Oct;7(10):e708-e718. doi: 10.1016/S2665-9913(25)00151-1. Epub 2025 Aug 12.
PMID: 40816302DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Enrollment was lower than expected due to the fact that most interested participants did not meet study inclusion criteria. As a result, we did not reach our pre-specified sample size of 80 participants. In addition, the institutional shutdown due to the COVID-19 pandemic resulted in 7 participants not completing the full 1-year intervention.
Results Point of Contact
- Title
- Julie Kolesar, PhD
- Organization
- Stanford University
Study Officials
- PRINCIPAL INVESTIGATOR
Julie Kolesar, PhD
VA Palo Alto Health Care System, Palo Alto, CA
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2016
First Posted
May 10, 2016
Study Start
August 1, 2016
Primary Completion
October 31, 2020
Study Completion
October 31, 2020
Last Updated
April 15, 2022
Results First Posted
April 15, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share